These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11704275

  • 1. Disruption of disulfide linkages of the Plasmodium falciparum circumsporozoite protein: effects on cytotoxic and antibody responses in mice.
    Rathore D, Kumar S, Lanar DE, McCutchan TF.
    Mol Biochem Parasitol; 2001 Nov; 118(1):75-82. PubMed ID: 11704275
    [Abstract] [Full Text] [Related]

  • 2. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA, McCoy ME, Doll TA, Brando C, Guo Q, Dasgupta D, Yang Y, Mittelholzer C, Spaccapelo R, Crisanti A, Burkhard P, Lanar DE.
    PLoS One; 2012 Nov; 7(10):e48304. PubMed ID: 23144750
    [Abstract] [Full Text] [Related]

  • 3. Antibodies elicited by Plasmodium falciparum circumsporozoite proteins lacking sequentially deleted C-terminal amino acids reveal mouse strain and epitopes specific differences.
    Hayashi CTH, Cao Y, Zavala F, Simonyan H, Young CN, Kumar N.
    Vaccine; 2023 Nov 02; 41(46):6824-6833. PubMed ID: 37827967
    [Abstract] [Full Text] [Related]

  • 4. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.
    Wang R, Epstein J, Charoenvit Y, Baraceros FM, Rahardjo N, Gay T, Banania JG, Chattopadhyay R, de la Vega P, Richie TL, Tornieporth N, Doolan DL, Kester KE, Heppner DG, Norman J, Carucci DJ, Cohen JD, Hoffman SL.
    J Immunol; 2004 May 01; 172(9):5561-9. PubMed ID: 15100299
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
    McCoy ME, Golden HE, Doll TA, Yang Y, Kaba SA, Zou X, Gerbasi VR, Burkhard P, Lanar DE.
    Malar J; 2013 Apr 22; 12():136. PubMed ID: 23607541
    [Abstract] [Full Text] [Related]

  • 6. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
    Chinchilla M, Pasetti MF, Medina-Moreno S, Wang JY, Gomez-Duarte OG, Stout R, Levine MM, Galen JE.
    Infect Immun; 2007 Aug 22; 75(8):3769-79. PubMed ID: 17502396
    [Abstract] [Full Text] [Related]

  • 7. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.
    Nardin E, Munesinghe YD, Moreno A, Clavijo P, Calle MC, Edelman R, Davis J, Herrington D, Nussenzweig RS.
    Mem Inst Oswaldo Cruz; 1992 Aug 22; 87 Suppl 3():223-7. PubMed ID: 1364202
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids.
    Wang R, Doolan DL, Charoenvit Y, Hedstrom RC, Gardner MJ, Hobart P, Tine J, Sedegah M, Fallarme V, Sacci JB, Kaur M, Klinman DM, Hoffman SL, Weiss WR.
    Infect Immun; 1998 Sep 22; 66(9):4193-202. PubMed ID: 9712767
    [Abstract] [Full Text] [Related]

  • 9. Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection.
    Scally SW, Murugan R, Bosch A, Triller G, Costa G, Mordmüller B, Kremsner PG, Sim BKL, Hoffman SL, Levashina EA, Wardemann H, Julien JP.
    J Exp Med; 2018 Jan 02; 215(1):63-75. PubMed ID: 29167197
    [Abstract] [Full Text] [Related]

  • 10. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B, Houghten RA, Parker KC, Coligan JE, Church P, Gordon DM, Ballou WR, Hoffman SL.
    J Exp Med; 1995 Nov 01; 182(5):1435-45. PubMed ID: 7595214
    [Abstract] [Full Text] [Related]

  • 11. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
    Powell TJ, Tang J, Derome ME, Mitchell RA, Jacobs A, Deng Y, Palath N, Cardenas E, Boyd JG, Nardin E.
    Vaccine; 2013 Apr 08; 31(15):1898-904. PubMed ID: 23481177
    [Abstract] [Full Text] [Related]

  • 12. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM, Oliveira GA, Watta CO, Soverow J, Parra-Lopez C, Nardin EH.
    Infect Immun; 2006 Dec 08; 74(12):6929-39. PubMed ID: 17030584
    [Abstract] [Full Text] [Related]

  • 13. Protective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite protein.
    Iyori M, Nakaya H, Inagaki K, Pichyangkul S, Yamamoto DS, Kawasaki M, Kwak K, Mizukoshi M, Goto Y, Matsuoka H, Matsumoto M, Yoshida S.
    PLoS One; 2013 Dec 08; 8(8):e70819. PubMed ID: 23951015
    [Abstract] [Full Text] [Related]

  • 14. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.
    Birkett A, Lyons K, Schmidt A, Boyd D, Oliveira GA, Siddique A, Nussenzweig R, Calvo-Calle JM, Nardin E.
    Infect Immun; 2002 Dec 08; 70(12):6860-70. PubMed ID: 12438363
    [Abstract] [Full Text] [Related]

  • 15. Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes.
    White K, Krzych U, Gordon DM, Porter TG, Richards RL, Alving CR, Deal CD, Hollingdale M, Silverman C, Sylvester DR.
    Vaccine; 1993 Oct 08; 11(13):1341-6. PubMed ID: 7507624
    [Abstract] [Full Text] [Related]

  • 16. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.
    Hedstrom RC, Doolan DL, Wang R, Kumar A, Sacci JB, Gardner MJ, Aguiar JC, Charoenvit Y, Sedegah M, Tine JA, Margalith M, Hobart P, Hoffman SL.
    Int J Mol Med; 1998 Jul 08; 2(1):29-38. PubMed ID: 9854139
    [Abstract] [Full Text] [Related]

  • 17. Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol.
    Haddad D, Liljeqvist S, Ståhl S, Hansson M, Perlmann P, Ahlborg N, Berzins K.
    Scand J Immunol; 1999 May 08; 49(5):506-14. PubMed ID: 10320644
    [Abstract] [Full Text] [Related]

  • 18. Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.
    Murugan R, Scally SW, Costa G, Mustafa G, Thai E, Decker T, Bosch A, Prieto K, Levashina EA, Julien JP, Wardemann H.
    Nat Med; 2020 Jul 08; 26(7):1135-1145. PubMed ID: 32451496
    [Abstract] [Full Text] [Related]

  • 19. Malaria DNA vaccines in Aotus monkeys.
    Gramzinski RA, Maris DC, Doolan D, Charoenvit Y, Obaldia N, Rossan R, Sedegah M, Wang R, Hobart P, Margalith M, Hoffman S.
    Vaccine; 1997 Jun 08; 15(8):913-5. PubMed ID: 9234546
    [Abstract] [Full Text] [Related]

  • 20. Identification of a nonameric H-2Kk-restricted CD8+ cytotoxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein.
    Malik A, Houghten R, Corradin G, Buus S, Berzofsky JA, Hoffman SL.
    Infect Immun; 1995 May 08; 63(5):1955-9. PubMed ID: 7537251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.